Personalized Treatment

Majority of Neurology and Neuropsychiatry patients are refractory patients and do not respond to treatment. Today, the response of these patients to medication is evaluated only on symptoms. Due to factors such as genetic structure and metabolic rate (polymorphism), response to medication varies between individuals. KİMER (Personalized Treatment Application and Research Center) is a center that provides preliminary information to the individual and the physician about possible polymorphisms and helps in regulating pharmacotherapy by measuring the response of the individual to the drug through Drug Blood Level Monitoring (TDM).